PHP
CUTR

Parkman Healthcare Partners’s Cutera, Inc. CUTR Stock Holding History

Parkman Healthcare Partners’s Portfolio CUTR Stock Details CUTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,000
Closed -$602K – 107
2023
Q3 		$602K Buy
+100,000
New +$1.27M 0.11% 99

Other funds holding CUTR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Parkman Healthcare Partners's CUTR Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of Cutera, Inc. (CUTR) in Q4 2023, closing a stake of 100,000 shares — an estimated $602K sold.

Parkman Healthcare Partners first reported a position in CUTR in Q3 2023 and held it in 1 quarter. The position peaked at $602K in Q3 2023. 100 funds tracked by Wall St. Rank hold CUTR as of Q4 2023.

  • Parkman Healthcare Partners reported no remaining Cutera, Inc. position as of Q4 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,000 Cutera, Inc. shares in Q4 2023, an estimated $602K.
  • Parkman Healthcare Partners first reported a position in Cutera, Inc. in Q3 2023 and held it in 1 quarter.
  • Parkman Healthcare Partners's Cutera, Inc. position peaked at $602K in Q3 2023.
  • 100 funds tracked by Wall St. Rank held Cutera, Inc. as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.